Business Wire

Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management

PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan ® family of products, today announces the global launch of FibroScan-based Agile scores to easily ...
Business Wire

Study Validating Echosens FibroScan FAST Score for Cost-Effective, Efficient Identification of People at Risk for Active Fibrotic NASH Published in Lancet Gastroenterology ...

WALTHAM, Mass. & PARIS--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, today announces the publication of the “FibroScan-AST (FAST) Score For The ...
Healio

Q&A: FAST score, other noninvasive tests help identify, stratify at-risk MASH patients

Please provide your email address to receive an email when new articles are posted on . Researchers recommended the FibroScan-AST score to target those at risk for MASH. The score should be used with ...
Onlymyhealth on MSN

Who should get a FibroScan? Gastroenterologist explains who may need this liver test

A FibroScan is a non-invasive test that can help doctors assess the health of the liver without a biopsy. It measures liver stiffness, which can indicate the presence and severity of liver fibrosis, ...
Healio

VIDEO: FAST, Agile 3+ scores may predict treatment benefit in MASH, advanced fibrosis

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Agile 3+ correctly identified more patients at high risk ...
Yahoo Finance

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

WESTBOROUGH, Mass., Sept. 8, 2025 /PRNewswire/ -- Echosens, the leader in non-invasive liver diagnostics, is announcing today that the U.S. Food and Drug Administration's (FDA's) Center for Drug ...
markets.financialcontent

Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Researchers present findings at EASL International ...